RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0043-100461
Paralytischer Ileus mit Todesfolge unter Psychopharmakotherapie
Paralytic ileus with fatal consequence under psychotropic medicationPublikationsverlauf
Publikationsdatum:
23. Juni 2017 (online)
Zusammenfassung
Innerhalb eines Zeitraums von rund zwei Jahren kam es in der Region Bielefeld zu einer auffälligen Häufung von vier Todesfällen als Folge eines paralytischen Ileus. Alle vier Patienten litten unter einer psychotischen Störung und hatten langjährig stark wirksame Psychopharmaka eingenommen. Nach Ausschluss anderer Ursachen muss die anticholinerge Wirkung der Psychopharmaka als Todesursache angesehen werden. Neben einer Literaturübersicht ähnlicher Fälle werden pharmakologische Rezeptorbindungsprofile anticholinerg wirksamer Substanzen dargestellt und therapeutische Konsequenzen für die Praxis aufgezeigt, um weitere Todesfälle zu verhindern.
Abstract
In the area of Bielefeld there occurred a striking accumulation of four cases of death as a consequence of a paralytic ileus within a period of two years. All four patients suffered from a psychotic disorder and had taken psychotropic medication for many years. After exclusion of other causes, the anticholinergic effect of the psychotropic medication must be taken as the cause of death. A review of literature and pharmacological receptor profiles are presented. Therapeutic consequences are described in order to prevent more cases of death.
-
Literatur
- 1 Warnes H. Lehmann HE. Ban TA. Adynamic ileus furing psychoactive medication: a report of three fatal and five severe cases. J Canad Med Assoc 1967; 96: 112-113
- 2 Kemeny MM. Martin EC. Lane FC. et al. Abdominal distention and aortic obstruction associated with phenothiazines. JAMA 1980; 243 (07) 683-684
- 3 Giordano J. Huang A. Canter JW. Fatal paralytic ileus complicating phenothiazine therapy. South Med J 1975; 68: 351-353
- 4 Benlloch S. Perez-Aguilar F. Ponce J. et al. Chronic colonic pseudoobstruction secondary to neuroleptics. Gastroenterol Hepatol 2001; 24 (10) 500-502
- 5 Rondeau M. Weber JC. Nodot I. et al. Acute colonic pseudo-obstruction in internal medicine: etiology and prognosis, report of a retrospective study. Rev Med Interne 2001; 22 (06) 536-541
- 6 Bender S. Grohmann R. Engel RR. et al. Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics. Pharmacopsychiatry 2004; 37 (Suppl. 01) 46-53
- 7 Lu MK. Clinical analysis in the main side effects of clozapine: enclosed 600 cases report. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1991; 24 (02) 71-74, 123
- 8 Erickson B. Morris DM. Reeve A. Clozapine-associated postoperative ileus: case report and review of the literature. Arch Gen Psychiatry 1995; 52: 508-509
- 9 Schneider B. Weigmann H. Hiemke C. et al. Reduction of clozapine-in-duced hypersalivation by pirenzepine is safe. Pharmacopsychiatry 2004; 37: 43-45
- 10 Laker MK. Cookson JK. Reflux oesophagitis and clozapine. Int Clin Psychopharmacol 1997; 12: 37-39
- 11 Eronen M. Putkonen H. Hallikainen T. et al. Lethal gastroenteritis associated with clozapine and loperamide. Am J Psychiatry 2003; 160: 2242-2243
- 12 Degner D. Kamphausen BH. Grohmann R. et al. Paralytischer Ileus und Mallory-Weiss-Syndrom mit tödlichem Verlauf unter Clozapin. Psychopharamakotherapie 2004; 3: 96-97
- 13 Ferslew KE. Hagardorn AN. Harlan GC. et al. A fatal drug interaction between clozapine and fluoxetine. J Forensic Sci 1998; 43 (05) 1082-1085
- 14 Gaszner G. Kosza P. Paralytic ileus during haloperidol therapy. Neuropsychopharmacology Hung 2004; 6 (01) 36-38
- 15 Maltbie AA. Varia IG. Thomas NU. Ileus complicating haloperidol therapy. Psychosomatics 1981; 22 (02) 158-159
- 16 Sirois FJ. Haloperidol-induced ileus. Psychosomatics 2005; 46: 275-276
- 17 Sheikh RA. Prindiville T. Yasmeen S. Haloperidol and benztropine interaction presenting as acute intestinal pseudo-obstruction. Am J Gastroenterol 2001; 96 (03) 934-935
- 18 Milner G. Buckler EG. Adynamic ileus and amitriptyline: three case reports. Med J Austra 1964; 24 (13) 921-922
- 19 Nielsen J. Meyer JM. Risk factors for ileus in patients with schizophrenia. Schizophr Bull 2012; 38 (03) 592-598
- 20 Arnt J. Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 1998; 18 (02) 63-101
- 21 Bolden C. Cusack B. Richelson E. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in chinese hamster ovary cells. J Pharmacol Exp Ther 1992; 260: 576-580
- 22 Bymaster FP. Calligaro DO. Falcone JF. et al. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 1996; 14 (02) 87-96
- 23 Markowitz JS. Brown CS. Moore TR. Atypical antipsychotics, Part I: pharmacology, pharmacokinetics, and efficacy. Ann Pharmacother 1999; 33: 73-85
- 24 Reinbold H. Psychogenicum: Taschenbuch mit Themen aus der Psychiatrie. Dortmund: PsychoGen Verlag; 2001
- 25 Lu C. Tune LE. Chronic exposure to anticholinergic medications adversely affetcs the course of alzheimer disease. Am J Geriatric Psychiatry 2003; 11: 4
- 26 Mintzer J. Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med 2000; 93: 457-462
- 27 Woodring JH. Martin CA. Keefer B. Esophageal atony and dilatation as a side effect of thiothixene and benztropine. Hosp Community Psychiatry 1993; 44 (07) 686-688
- 28 Sriram K. Schumer W. Ehrenpreis S. et al. Phenothiazine effect on gastrointestinal tract function. Am J Surg 1979; 137 (01) 87-91
- 29 Szanto P. Ehrenpreis E. Krakow M. et al. Histologic changes in the guinea pig gastrointestinal tract following 1 weeks´ administration of chlorpromazine, haloperidol or atropine. Psychopharmacology 1998; 95 (03) 351-355
- 30 Wetterling T. Gewichtszunahme bei Gabe von atypischen Neuroleptika – eine unterschätzte Nebenwirkung?. Fortschr Neurol Psychiat 2000; 68: 546-556
- 31 Turnheim K. Adverse effects of psychotropic drugs in the elderly. Wien Klin Wochenschr 2000; 112 (09) 394-401